HOUSE 1362116th CongressReferred to the Subcommittee on Health.
Medical Innovation Never Stops Act of 2019
- Last Action
- 2/27/2019
Actions
- 2019-02-27Referred to the Subcommittee on Health.
- 2019-02-26Referred to the House Committee on Energy and Commerce.
- 2019-02-26Introduced in House
- 2019-02-26Introduced in House
CRS Summary
As of 2019-02-26 (00)
Medical Innovation Never Stops Act of 2019
This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Subjects
- Appropriations
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Executive agency funding and structure
- Licensing and registrations
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.